Condition (MeSH)
Hearing Loss, Conductive
ClinicalTrials.gov lists 81 trials for Hearing Loss, Conductive or a narrower condition beneath it. Oticon Medical has the most among industry and government lead sponsors, with 19.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
81 of the 81 trials are tagged with Hearing Loss, Conductive itself; the rest are tagged with a narrower condition beneath it.
When did Hearing Loss, Conductive trials start? (18)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 10
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 6 |
| 2025 | 6 |
| 2024 | 4 |
| 2023 | 2 |
| 2022 | 5 |
| 2021 | 6 |
| 2020 | 4 |
| 2019 | 10 |
| 2018 | 8 |
| 2017 | 8 |
Showing 10 of 18 earlier years.
No forecast is made for this condition: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 32 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 13 months across 56 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hearing Loss, Conductive trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 3 |
| Not applicable | 58 |
| Observational | 20 |
How many Hearing Loss, Conductive trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 4 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Completed | 49 |
| Terminated | 4 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hearing Loss, Conductive trials? (9)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Oticon Medical | 19 |
| Cochlear | 11 |
| Cochlear Bone Anchored Solutions | 4 |
| MED-EL Elektromedizinische Geräte GesmbH | 3 |
| Med-El Corporation | 3 |
Showing 5 of 9 sponsors.
Which drugs are being tested for Hearing Loss, Conductive? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Deflazacort | 1 |
| Montelukast | 1 |
| Bilastine | 1 |
Interventions as named in the registry (2)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Mometasone furoate as a nasal spray | 1 |
| OCT - clear | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Hearing Loss, Conductive trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cholesteatoma | 2 | 2 |
| Implant site pain | 2 | 1 |
| Pneumonia | 2 | 2 |
| Postoperative wound infection | 2 | 1 |
| Accidental Death | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Hearing Loss, Conductive? (40)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Outcomes Following Cochlear Osia 2 Implantation in Patients Ages 5-11 Years: A Multi-Center Trial. | The Laryngoscope | 2025 | Yes |
| Audiological benefit and subjective satisfaction of children with the ADHEAR audio processor and adhesive adapter. | International journal of pediatric otorhinolaryngology | 2020 | Yes |
| Clinical performance of the Osia™ system, a new active osseointegrated implant system. Results from a prospective clinical investigation. | Acta oto-laryngologica | 2020 | Yes |
| Cone beam versus multi-detector computed tomography for detecting hearing loss. | European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2019 | Yes |
| Investigating sudden hearing loss in adults. | BMJ (Clinical research ed.) | 2018 | Yes |
Showing 5 of 40 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.